OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 74 filers reported holding OCULAR THERAPEUTIX INC in Q3 2018. The put-call ratio across all filers is 0.57 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $69 | -100.0% | 13,383 | +5.9% | 0.01% | -70.6% |
Q2 2021 | $179,000 | -31.7% | 12,641 | -20.7% | 0.02% | -10.5% |
Q1 2021 | $262,000 | +77.0% | 15,938 | -18.1% | 0.02% | -24.0% |
Q3 2020 | $148,000 | -21.7% | 19,459 | -59.3% | 0.02% | +38.9% |
Q4 2019 | $189,000 | +509.7% | 47,820 | +374.2% | 0.02% | +800.0% |
Q3 2019 | $31,000 | -77.9% | 10,085 | -51.2% | 0.00% | -66.7% |
Q2 2018 | $140,000 | +6.9% | 20,672 | +2.6% | 0.01% | -14.3% |
Q1 2018 | $131,000 | -53.2% | 20,139 | -68.0% | 0.01% | -53.3% |
Q4 2017 | $280,000 | – | 63,020 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SUMMER ROAD LLC | 5,944,761 | $23,898,000 | 100.00% |
Opaleye Management Inc. | 5,974,800 | $24,019,000 | 10.83% |
DELTEC ASSET MANAGEMENT LLC | 2,069,313 | $8,319,000 | 1.95% |
Kamunting Street Capital Management, L.P. | 275,506 | $1,108,000 | 1.50% |
Altium Capital Management LP | 695,000 | $2,794,000 | 1.12% |
Endurant Capital Management LP | 760,228 | $3,056,000 | 1.07% |
EMERALD ADVISERS, LLC | 1,465,702 | $5,892,000 | 0.30% |
MSD Partners, L.P. | 1,016,302 | $4,086,000 | 0.25% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,044,732 | $4,200,000 | 0.24% |
NOTTINGHAM ADVISORS, INC. | 194,266 | $781,000 | 0.11% |